These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology. Jones GL; Will A; Jackson GH; Webb NJ; Rule S; Br J Haematol; 2015 Jun; 169(5):661-71. PubMed ID: 25876990 [No Abstract] [Full Text] [Related]
36. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Cairo MS; Coiffier B; Reiter A; Younes A; Br J Haematol; 2010 May; 149(4):578-86. PubMed ID: 20331465 [TBL] [Abstract][Full Text] [Related]
37. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature. Baeksgaard L; Sørensen JB Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435 [TBL] [Abstract][Full Text] [Related]
38. The management of tumor lysis syndrome. Rampello E; Fricia T; Malaguarnera M Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome. Jeon YW; Kwak DH; Park SS; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):595-603. PubMed ID: 28711571 [TBL] [Abstract][Full Text] [Related]
40. The clinical management of tumour lysis syndrome in haematological malignancies. Will A; Tholouli E Br J Haematol; 2011 Jul; 154(1):3-13. PubMed ID: 21554259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]